Seven Bridge Financial Group, LLC Invitae Corp Transaction History

Seven Bridge Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$1.9 - $8.63 $8,542 - $38,800	-4,496 Reduced 11.65%	34,103 $84,000
Q2 2022 Jul 12, 2022	SELL	$2.13 - $9.01 $3,452 - $14,605	-1,621 Reduced 4.03%	38,599 $94,000
Q1 2022 Apr 15, 2022	SELL	$6.28 - $15.59 $25,704 - $63,809	-4,093 Reduced 9.24%	40,220 $321,000
Q4 2021 Jan 20, 2022	BUY	$14.7 - $28.67 $651,401 - $1.27 Million	44,313 New	44,313 $677,000
Q4 2021 Jan 20, 2022	SELL	$14.7 - $28.67 $650,372 - $1.27 Million	-44,243 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$24.31 - $33.6 $38,507 - $53,222	-1,584 Reduced 3.46%	44,243 $1.26 Million
Q2 2021 Jul 26, 2021	BUY	$26.09 - $40.4 $1.2 Million - $1.85 Million	45,827 New	45,827 $1.55 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.